旋入式髓内钉治疗肱骨干骨折

目的介绍和总结旋入式髓内钉治疗肱干骨折的方法及疗效.方法自2000年6月～2003年10月采用旋入式髓内钉顺行植入治疗肱骨干骨折12例,术后不用外固定,一周后进行适当功能锻炼;粉碎性骨折石膏固定6周后,开始功能锻炼.结果本组1 2例,均经3个月～2年随访,获得愈合,无并发症出现.按Neer功能评分标准,优良率100%.结论旋入式髓内钉治疗肱骨干骨折,固定牢靠,并发症少,愈合率高,功能恢复良好,是一种有效的治疗方法.     

Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy

Dendritic cells (DC) are increasingly explored as cellular vaccines for tumor immunotherapy. In most reported DC-based cancer vaccine trials, DC have been pulsed with soluble tumor antigen-derived peptide ligands of MHC molecules. Considering that the half-life of peptide/MHC complexes on the cell surface is relatively short and that soluble exogenous protein antigens cannot be efficiently processed via the MHC class I-processing pathway, the current vaccination procedure is not optimal for the induction of strong T cell responses aiming at tumor rejection. Recently, we have shown that antigen presentation can be prolonged when synthetic peptides were encapsulated in biodegradable poly(D,L-lactide-co-glycolide) (PLGA) microspheres (MS) for uptake by DC. In the present study, we investigated the phenotypic and functional consequences of MS uptake by human monocyte-derived dendritic cells (MoDC) in vitro. We found that immature MoDC that were prepared in serum free media suitable for clinical application were able to phagocytose high numbers of MS, while matured MoDC showed a reduced capacity for phagocytosis of MS. The ingestion of MS did not change the cell surface expression of CD80, CD83, CD86 and HLA-DR of immature and mature DC, suggesting that MS uptake did not induce DC maturation but that maturation by cytokines or LPS was unaltered in the presence of MS. Furthermore, MS-loaded mature MoDC expressed normal levels of the chemokine receptor CCR7 and migrated as efficiently towards CCL19 or CCL21 as unloaded MoDC. DC viability and the secretion of TNF-alpha and IL-12 was not significantly changed by MS loading. Taken together, our data indicate that PLGA-MS loading has no negative effects on the pivotal properties of MoDC in vitro. It should therefore be feasible to further develop this antigen loading strategy for clinical use in immunotherapy against viral infections and tumors.     

幕上高血压脑出血预后影响因素的多重线性回归分析

目的探讨影响幕上高血压脑出血（SICH）患者预后的相关因素,以指导临床治疗和评估预后。方法回顾性分析符合本研究纳入标准的幕上高血压脑出血324例完整病历。以一般资料、起病症状、入院查体、影像学资料、治疗方式、并发症等43项为自变量,以发病后1个月后功能独立性评定评分（functional independence measure,FIM）为因变量,建立多重线性回归模型,筛选出对预后有影响的因素,并比较各因素的影响大小。结果经统计学处理发现血肿体积、入院时收缩期血压、GCS评分、脑室是否积血、血肿体积扩大、是否并发肺部感染和应激性溃疡等7项对预后有显著性的影响。结论血肿体积、入院GCS评分和脑室是否积血对预后影响有重要意义,可作为SICH患者预后的关键性指标。     

豚鼠耳蜗Hensen细胞的分离、活性鉴定及其胞内静态游离Ca~(2+)分布

使用酶消化法及机械分离法对 Hensen细胞进行分离 ,置于倒置显微镜下用碘化丙啶及钙敏荧光染料 Fluo-3进行细胞活性鉴定并在激光扫描共聚焦显微镜下观察静息状态 Hensen细胞内的游离 Ca2 +的时空分布。结果证明 ,每个豚鼠耳蜗可以得到单离的 Hensen细胞 5～ 12个。细胞活性良好 ,可保持 5～ 6h。当细胞变性、坏死时可见一系列的形态学变化。对此得出几点判断 Hensen细胞活性的标准 :(1)细胞体呈卵圆形或椭圆形 ,大小可不一致 ;(2 )细胞膜完整 ,细胞边界清楚 ,折光现象明显 ;(3 )细胞浆清澈透明 ,无布朗运动 ,无溢出 ;(4 )细胞浆内的脂滴清晰可辨 ,折光现象明显 ;(5 )细胞无水肿 (即无气球样变 )。在静息状态下 ,Hensen细胞内的 Ca2 + 在细胞内分布不均匀 ,脂滴所在部位没有 Ca2 + 的分布。随时间延长 ,细胞内的 [Ca2 + ] i可小幅度振荡 ,但基本处于一种稳定状态。本工作为进一步对 Hensen细胞的其他特性进行研究打下了基础     

同种与异种骨基质明胶修复颅骨缺损的实验研究

以家兔颅顶骨直径１０ｍｍ园形骨缺损作为动物模型，分别植入同种（兔）、异种（人、猪、羊）的骨基质明胶。植入后４、８、１２、１６ｗ进行ｘ线摄片和组织学检查。结果显示，同种骨基质明胶无免疫排斥反应，具有良好的骨诱导作用，术后１２ｗ骨缺损完全修复；异种骨基质明胶植入早期，存在着不同程度的排斥反应，植骨后期（１２～１６ｗ），随着排斥反应的减轻，亦出现了诱导成骨。结果说明，如能改进异种骨基质明胶的制作方法，降低其抗原性，将具有重要的临床应用价值。     

促肝细胞生长素诱导人肝癌细胞（BEL－7402）凋亡

本文从细胞学、ＤＮＡ凝胶电泳、流式细胞术三方面研究促肝细胞生长素（ｐＨＧＦ）在体外对肝癌细胞增殖活性的影响。结果表明：ｐＨＧＦ对肝癌ＢＥＬ－７４０２细胞增殖有抑制作用，并存在剂量和时间相关性。其４８ｈ的半数抑制浓度（ＩＤ５０）为０．３７ｍｇ／ｍｌ±０．０４ｍｇ／ｍｌ。而３７℃灭活的ｐＨＧＦ对ＢＥＬ－７４０２细胞增殖在１５ｈ无抑制作用，在２４和４８ｈ抑制作用很弱（ＩＤ５０＞１．５ｍｇ／ｍｌ）。ＤＮＡ凝胶电泳结果表明，ｐＨＧＦ可诱导ＢＥＬ７４０２细胞产生细胞凋亡（Ａｐｏｐｔｏｓｉｓ）。流式细胞术（ＦＣＭ）结果显示：ｐＨＧＦ抑制ＢＥＬ－７４０２细胞增殖过程是先使细胞停留在Ｇ０／Ｇ１期，继而诱导细胞产生凋亡。后两项结果均显示ｐＨＧＦ对人肝癌细胞凋亡的诱导里时间和剂量相关性。     

额外小染色体与原发闭经(附4例报告)

我们发现4例原发闭经伴额外小染色体病例,其核型分别为;46,XX/47,XX mar;46,X,del(X)/47,X,del(X) mar;47,XX, mar;45,X/46,X, mar/46,X r.作者讨论了mar的发生率、起源、诊断、临床表现及产前诊断等问题.     

大鼠胸腺降黑素受体的鉴定及生物学特性

应用放射配体结合法证实大鼠胸腺内存在降黑素特异结合部位，该结合位点可以满足特异结合部位的基本条件：１．低结合容量；２．高亲和力；３．可饱和性；４．可逆性；５．对降黑素高度特异性。此外，该特异结合位点具昼夜节律；亚细胞分布的研究表明以细胞核含量最高，线粒体次之，并具有年龄依赖性降低，以出生时最高。     

Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors.

The diagnosis of thyroid tumors is critical for clinical management; however, tumors with follicular architecture often present problems. We evaluated the diagnostic use of the protein expression of four genes that were found to be upregulated in papillary thyroid carcinoma compared to normal thyroid (LGALS3, FN1, CITED1 and KRT19), and of the mesothelial cell surface protein recognized by monoclonal antibody HBME1 in thyroid tumors. Tissues from 85 carcinomas (67 papillary, six follicular, eight Hürthle cell and four anaplastic) and 21 adenomas were evaluated by immunohistochemistry for the expression of these gene protein products, for example, galectin-3 (GAL3), fibronectin-1 (FN1), CITED1, cytokeratin-19 (CK19) and HBME1. Non-neoplastic thyroids (29 adenomatous and 14 thyrotoxic hyperplasia, and 59 normal) were also studied. The expression of all five proteins was significantly associated with malignancy, and highly specific (> or = 90%) for carcinoma compared to adenoma. GAL3, FN1 and/or HBME1 expression was seen in 100% of carcinomas (85/85) and in 24% of adenomas (5/21). Coexpression of multiple proteins was seen in 95% of carcinomas and only 5% of adenomas (P<0.0001). Coexpression of FN1 and GAL3 (FN1+ GAL3+, 70/85) or FN1 and HBME1 (FN1+ HBME1+, 53/85) was restricted to carcinomas, while their concurrent absence (FN1- GAL3- or FN1- HBME1-, 18/21 adenoma) was highly specific (96%) for benign lesions. Among non-neoplastic thyroids, adenomatous hyperplasia frequently expressed GAL3 (n=16), CK19 (n=9) and CITED1 (n=7), but the expression was predominantly focal in contrast to the diffuse expression in carcinomas. An immunohistochemical panel consisting of GAL3, FN1 and HBME1 may be useful in the diagnosis of follicular cell-derived thyroid tumors.     

乌鲁木齐市维吾尔族长寿家族成员第二掌骨骨皮质的X线形态学测量分析

用Ｘ线形态学测量方法，对乌鲁木齐部分维吾尔族长寿老人及其家族成员的第二掌骨骨皮质进行了测量。结果表明１０￣３９岁组骨皮质厚度，皮质厚度指数，皮质面积随年龄增长而增大，３０￣３９岁组达到峰值，其中骨皮质厚度、皮质面积的数值男性〉女性，３０￣３９岁组差别有显著性。４０岁以后各组数值开始下降，其下降速度女性快于男性，９０岁以上组最为明显，有显著性差异。